TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive NCCR Seeks #380 Mil. Increase For NIC In FY 1994; Calls ‘First Step’ In Reaching Byspass Budget Level February 26, 1993
TCL Archive Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives. October 3, 2003
TCL Archive In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure July 5, 1991
